The "DNA Methylation Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global DNA methylation market, valued at an estimated USD 1.64 billion in 2024, is anticipated to ...
A new proteomic analysis is shedding a fresh light on the cytokine networks fueling idiopathic pulmonary fibrosis (IPF), ...
To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...
The Asia Society Policy Institute’s Center for China Analysis aims to become a leading global think tank committed to decoding China's complexities with an "inside-out" approach by offering ...
The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...
New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, offering hope to affected families.
The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.
Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about half are caused by genetic or chromosomal issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback